Literature DB >> 29490150

Tuberculosis Mortality in the United States: Epidemiology and Prevention Opportunities.

Suzanne F Beavers1, Lisa Pascopella2, Amy L Davidow3, Joan M Mangan4, Yael R Hirsch-Moverman5, Jonathan E Golub6, Henry M Blumberg7, Risa M Webb8, Rachel A Royce9, Susan E Buskin10, Michael K Leonard11, Paul C Weinfurter12, Robert W Belknap13, Stephen E Hughes14, Jon V Warkentin15, Sharon F Welbel16, Thaddeus L Miller17, Saini R Kundipati18, Michael Lauzardo4, Pennan M Barry2, Dolly J Katz1, Denise O Garrett1, Edward A Graviss19, Jennifer M Flood2.   

Abstract

Rationale: More information on risk factors for death from tuberculosis in the United States could help reduce the tuberculosis mortality rate, which has remained steady for more than a decade.Objective: To identify risk factors for tuberculosis-related death in adults.
Methods: We performed a retrospective study of 1,304 adults with tuberculosis who died before treatment completion and 1,039 frequency-matched control subjects who completed tuberculosis treatment in 2005 to 2006 in 13 states reporting 65% of U.S. tuberculosis cases. We used in-depth record abstractions and a standard algorithm to classify deaths in persons with tuberculosis as tuberculosis-related or not. We then compared these classifications to causes of death as coded in death certificates. We used multivariable logistic regression to calculate adjusted odds ratios for predictors of tuberculosis-related death among adults compared with those who completed tuberculosis treatment.
Results: Of 1,304 adult deaths, 942 (72%) were tuberculosis related, 272 (21%) were not, and 90 (7%) could not be classified. Of 847 tuberculosis-related deaths with death certificates available, 378 (45%) did not list tuberculosis as a cause of death. Adjusting for known risks, we identified new risks for tuberculosis-related death during treatment: absence of pyrazinamide in the initial regimen (adjusted odds ratio, 3.4; 95% confidence interval, 1.9-6.0); immunosuppressive medications (adjusted odds ratio, 2.5; 95% confidence interval, 1.1-5.6); incomplete tuberculosis diagnostic evaluation (adjusted odds ratio, 2.2; 95% confidence interval, 1.5-3.3), and an alternative nontuberculosis diagnosis before tuberculosis diagnosis (adjusted odds ratio, 1.6; 95% confidence interval, 1.2-2.2).Conclusions: Most persons who died with tuberculosis had a tuberculosis-related death. Intensive record review revealed tuberculosis as a cause of death more often than did death certificate diagnoses. New tools, such as a tuberculosis mortality risk score based on our study findings, may identify patients with tuberculosis for in-hospital interventions to prevent death.

Entities:  

Keywords:  cause of death; death certificates; risk factors

Year:  2018        PMID: 29490150      PMCID: PMC6531349          DOI: 10.1513/AnnalsATS.201705-405OC

Source DB:  PubMed          Journal:  Ann Am Thorac Soc        ISSN: 2325-6621


  35 in total

Review 1.  An official ATS statement: hepatotoxicity of antituberculosis therapy.

Authors:  Jussi J Saukkonen; David L Cohn; Robert M Jasmer; Steven Schenker; John A Jereb; Charles M Nolan; Charles A Peloquin; Fred M Gordin; David Nunes; Dorothy B Strader; John Bernardo; Raman Venkataramanan; Timothy R Sterling
Journal:  Am J Respir Crit Care Med       Date:  2006-10-15       Impact factor: 21.405

2.  Tuberculosis in the intensive care unit: a descriptive analysis in a low-burden country.

Authors:  J-P Lanoix; S Gaudry; R Flicoteaux; R Ruimy; M Wolff
Journal:  Int J Tuberc Lung Dis       Date:  2014-05       Impact factor: 2.373

3.  Tuberculosis deaths in countries with high HIV prevalence: what is their use as an indicator in tuberculosis programme monitoring and epidemiological surveillance?

Authors:  D Maher; C J Watt; B G Williams; M Raviglione; C Dye
Journal:  Int J Tuberc Lung Dis       Date:  2005-02       Impact factor: 2.373

4.  Mortality before or during treatment among tuberculosis patients in North Carolina, 1993-2003.

Authors:  L T Nguyen; C D Hamilton; Q Xia; J E Stout
Journal:  Int J Tuberc Lung Dis       Date:  2011-02       Impact factor: 2.373

5.  Sociodemographic and Clinical Risk Factors Associated With Tuberculosis Mortality in the United States, 2009-2013.

Authors:  Haylea A Hannah; Roque Miramontes; Neel R Gandhi
Journal:  Public Health Rep       Date:  2017-04-10       Impact factor: 2.792

6.  Hospitalizations for tuberculosis in the United States in 2000: predictors of in-hospital mortality.

Authors:  Nadia N Hansel; Barry Merriman; Edward F Haponik; Gregory B Diette
Journal:  Chest       Date:  2004-10       Impact factor: 9.410

7.  Costs and cost-effectiveness of four treatment regimens for latent tuberculosis infection.

Authors:  David P Holland; Gillian D Sanders; Carol D Hamilton; Jason E Stout
Journal:  Am J Respir Crit Care Med       Date:  2009-03-19       Impact factor: 21.405

8.  The impact of comorbidity on mortality following in-hospital diagnosis of tuberculosis.

Authors:  V K Rao; E P Iademarco; V J Fraser; M H Kollef
Journal:  Chest       Date:  1998-11       Impact factor: 9.410

9.  The influence of diabetes, glycemic control, and diabetes-related comorbidities on pulmonary tuberculosis.

Authors:  Chen Yuan Chiang; Kuan Jen Bai; Hsien Ho Lin; Shun Tien Chien; Jen Jyh Lee; Donald A Enarson; Ting-I Lee; Ming-Chih Yu
Journal:  PLoS One       Date:  2015-03-30       Impact factor: 3.240

10.  The effect of tuberculosis on the mortality of cirrhotic patients: a population-based 3-year follow-up study.

Authors:  Tsung-Hsing Hung; Chorng-Jang Lay; Chih-Wei Tseng; Chih-Chun Tsai; Chen-Chi Tsai
Journal:  Medicine (Baltimore)       Date:  2014-12       Impact factor: 1.889

View more
  7 in total

1.  Not So Fast: Slowing Tuberculosis Decline in California.

Authors:  Julie Higashi; Pennan Barry
Journal:  Am J Public Health       Date:  2019-02       Impact factor: 9.308

2.  Residential urban tree canopy is associated with decreased mortality during tuberculosis treatment in California.

Authors:  Robert J Blount; Lisa Pascopella; Pennan Barry; Joseph Zabner; Emma M Stapleton; Jennifer Flood; John Balmes; Payam Nahid; Donald G Catanzaro
Journal:  Sci Total Environ       Date:  2019-11-20       Impact factor: 7.963

3.  Policy Implications of Mathematical Modeling of Latent Tuberculosis Infection Testing and Treatment Strategies to Accelerate Tuberculosis Elimination.

Authors:  Suzanne M Marks; David W Dowdy; Nicolas A Menzies; Priya B Shete; Joshua A Salomon; Andrea Parriott; Sourya Shrestha; Jennifer Flood; Andrew N Hill
Journal:  Public Health Rep       Date:  2020 Jul/Aug       Impact factor: 2.792

4.  The Health and Economic Benefits of Tests That Predict Future Progression to Tuberculosis Disease.

Authors:  Nicolas A Menzies; Sourya Shrestha; Andrea Parriott; Suzanne M Marks; Andrew N Hill; David W Dowdy; Priya B Shete; Ted Cohen; Joshua A Salomon
Journal:  Epidemiology       Date:  2022-01-01       Impact factor: 4.822

Review 5.  A narrative review of tuberculosis in the United States among persons aged 65 years and older.

Authors:  Iris L Wu; Amit S Chitnis; Devan Jaganath
Journal:  J Clin Tuberc Other Mycobact Dis       Date:  2022-06-13

6.  Tuberculosis Transmission or Mortality Among Persons Living with HIV, USA, 2011-2016.

Authors:  K M Schmit; N Shah; S Kammerer; S Bamrah Morris; S M Marks
Journal:  J Racial Ethn Health Disparities       Date:  2020-02-14

7.  Association of Tumor Necrosis Factor α Inhibitor Use with Diagnostic Features and Mortality of Tuberculosis in the United States, 2010-2017.

Authors:  Shereen S Katrak; Rongxia Li; Sue Reynolds; Suzanne M Marks; Jessica R Probst; Terence Chorba; Kevin Winthrop; Kenneth G Castro; Neela D Goswami
Journal:  Open Forum Infect Dis       Date:  2021-12-22       Impact factor: 3.835

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.